In line with our results, a cohort analysis by Kumar and colleagues revealed that the elevated levels of CXCL10 were associated with poor TB treatment outcomes, and could be a predictive marker for clinical outcomes (34, 35). This evidence concerns the gene CXCL10 and tuberculosis.